Tag: Adalimumab

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Adalimumab

Goelzer Investment Management Inc. Grows Position in AbbVie Inc. (NYSE:ABBV)

Added to Collection on: 2024-07-08 16:18:58

Tags for this article:

Financial ratios
Orphan drugs
AbbVie
Monoclonal antibodies
Equity securities
Dividend
Adalimumab
Price?earnings ratio
Short
Ex-dividend date
Ibrutinib
Stock
AbbVie Inc.
Goelzer Investment Management Inc

Click the tags to see associated articles and topics

View Article Details
The Zacks Analyst Blog Highlights Eli Lilly, Pfizer, AbbVie and Biogen - Yahoo Finance

Added to Collection on: 2024-08-14 14:12:47

Tags for this article:

Research and development in the United States
Financial ratios
Eli Lilly and Company
AbbVie
Pfizer
Adalimumab
Tirzepatide
Eli Lilly
Biogen
Dividend yield
United States

Click the tags to see associated articles and topics

View Article Details
Survey of Clinicians: Lower Cost of Biosimilars is the Main Driver of Treatment Choice in IBD

Added to Collection on: 2024-09-07 11:06:02

Tags for this article:

Monoclonal antibodies
Immunosuppressants
Autoimmune diseases
TNF inhibitors
Disease-modifying antirheumatic drugs
Biosimilar
Infliximab
Biopharmaceutical
Adalimumab
Crohn's disease
Ulcerative colitis
Inflammatory bowel disease

Click the tags to see associated articles and topics

View Article Details
The impact of EU public procurement regulations on tenders in Spain: a study with adalimumab

Added to Collection on: 2024-09-19 09:42:24

Tags for this article:

Pharmaceutical industry
Pharmaceuticals policy
Immunosuppressants
Monoclonal antibodies
TNF inhibitors
Biosimilar
Adalimumab
Government procurement
Biopharmaceutical
E-procurement
Medication
Generic drug
Spain

Click the tags to see associated articles and topics

View Article Details
Novo Nordisk's Ozempic, Regeneron/Sanofi's Dupixent set to advance in top drug sales

Added to Collection on: 2024-09-29 20:13:27

Tags for this article:

AbbVie
Adalimumab
Pfizer
IStock
BioNTech
New York Stock Exchange
Autoimmune disease
Getty Images

Click the tags to see associated articles and topics

View Article Details
Lilly touts Omvoh's superiority over J&J's Stelara in Crohn's - Clinical Trials Arena

Added to Collection on: 2024-10-15 14:33:59

Tags for this article:

Autoimmune diseases
Immunosuppressants
Monoclonal antibodies
Disease-modifying antirheumatic drugs
Abdominal pain
Biosimilar
Adalimumab
Crohn's disease
Inflammatory bowel disease
Eli Lilly and Company
Ulcerative colitis
Clinical trial

Click the tags to see associated articles and topics

View Article Details
Strategies to Boost Biosimilar Adoption and Improve Patient Access

Added to Collection on: 2024-10-17 16:32:38

Tags for this article:

Biopharmaceuticals
Biosimilar
Biotechnology
Biotechnology products
Pharmaceutical industry
Specialty drugs
Academy of Managed Care Pharmacy
Adalimumab
Medicare
Pharmacy benefit management
Association for Accessible Medicines
Specialty drugs in the United States
Sophia Humphreys
Justin Bioc

Click the tags to see associated articles and topics

View Article Details
Tweaks in drug formulations to extend copyrights is a public health challenge

Added to Collection on: 2024-10-28 06:07:02

Tags for this article:

Patent law
Specialty drugs
Pharmaceutical industry
Evergreening
Biosimilar
Biopharmaceutical
Novartis
Trastuzumab
Chemical patent
Patent
Adalimumab
United States
India

Click the tags to see associated articles and topics

View Article Details
Psoriasis biosimilars and pricing changes herald treatment paradigm disruptions

Added to Collection on: 2024-10-31 13:05:31

Tags for this article:

Immunosuppressants
Monoclonal antibodies
Disease-modifying antirheumatic drugs
TNF inhibitors
Pharmacy
Biosimilar
Biopharmaceutical
Psoriasis
Adalimumab
Ustekinumab
Etanercept
Amgen
Robert Popovian
United States
Stelara

Click the tags to see associated articles and topics

View Article Details
Biosimilars Month in Review: October 2024 - HCPLive

Added to Collection on: 2024-11-02 18:03:59

Tags for this article:

Immunosuppressants
Monoclonal antibodies
Disease-modifying antirheumatic drugs
TNF inhibitors
Janssen Biotech
Biosimilar
Adalimumab
Infliximab
Ustekinumab
Etanercept
Ulcerative colitis
Crohn's disease

Click the tags to see associated articles and topics

View Article Details